- Your cart is empty
- Continue Shopping
Mitant 12.5mg Capsule
Sunitinib
Uses of Mitant 12.5mg Capsule
Mitant 12.5mg Capsule is used in the treatment of the following condition:
- Renal cell carcinoma (RCC)
- Gastrointestinal stromal tumors (GIST)
- Pancreatic neuroendocrine tumors (PNET)
- Medullary thyroid cancer
- Certain kidney cancer
Introduction to Mitant 12.5mg Capsule
Mitant 12.5mg Capsule consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means that it works by blocking certain enzymes called tyrosine kinases that are involved in the growth and spread of cancer cells. This medication treats gastrointestinal stromal tumors (GIST), rare cancer that can start anywhere in the gastrointestinal tract. This medication is also used to treat advanced kidney cancer and pancreatic cancer called pancreatic neuroendocrine tumors (PNET). Cancer is a disorder in which abnormal cells grow in an uncontrolled manner. It is not recommended for people under 18.
Before taking Mitant 12.5mg Capsule, it is important to discuss with the physician if you have blood conditions, heart problems, liver disorders, kidney problems, skin disorders, diabetes, seizures, or thyroid disorders. Also, inform if you have recently had or are about to have surgery. Tell your doctor if you are hypertensive because this medication sometimes causes hypertension as a side effect. Avoid taking grapefruit in any form during the treatment with Mitant 12.5mg Capsule. Check with your dentist if you have any problems in the mouth, such as mouth pain, swelling, or sores inside the mouth, before starting treatment.
Therapeutic Effects of Mitant 12.5mg Capsule
The therapeutic effects of Mitant 12.5mg Capsule include slowing down or stopping the growth and spread of cancer cells in the body, thereby reducing the size and number of tumors. It works by inhibiting the activity of specific proteins known as tyrosine kinases, which are involved in the signaling pathways that control cell growth and division. It can help to prevent cancer cells from growing and spreading by blocking these pathways.
Interaction of Mitant 12.5mg Capsule with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Mitant 12.5mg Capsule and reduce effectiveness by causing undesirable side effects.
More Information about Mitant 12.5mg Capsule
- Mitant 12.5mg Capsule should be stored at room temperature, between 68°F and 77°F (20°C and 50°C).
- Keep it in the original package.
- Protected from moisture, light, and heat.
- Keep it out of reach from children and pets.
How to consume Mitant 12.5mg Capsule
Mitant 12.5mg Capsule is taken orally, in the form of capsules, with a glass of water. The capsules should be swallowed whole and not crushed, chewed, or opened. The recommended dose may vary depending on the type of cancer being treated, the patient’s age and weight, and other factors. This medication is usually taken once a day, with or without food, at around the same time each day. If you miss a dose, do not double the dose to compensate for the missed dose.
Safety Advices for Mitant 12.5mg Capsule
Pregnancy
Mitant 12.5mg Capsule is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Breast Feeding
It is unknown whether Mitant 12.5mg Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
Lungs
Mitant 12.5mg Capsule can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
Liver
Mitant 12.5mg Capsules can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should be done their liver function tests regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
Alcohol
It is generally recommended to avoid consuming alcohol during treatment with anticancer medication, as alcohol can potentially interfere with the effectiveness of the medication and increases the liver-related and other potential side effects.
Driving
Patients receiving Mitant 12.5mg Capsule are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient’s ability to drive or operate machinery safely.
Side Effects of Mitant 12.5mg Capsule
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Side effects related to Mitant 12.5mg Capsule are as follows:
Serious:
- Heart failure or heart attack
- Elevated liver function tests.
- Liver failure
- Proteinuria
- Acute kidney injury
- Interstitial lung disease (inflammation of lung walls)
- Pulmonary arterial hypertension
- Gastrointestinal perforation or fistula
- Haemorrhage (bleeding)
- Hypothyroidism (low thyroid function)
- Hypoglycemia (low blood sugar)
Common
- Fatigue
- Nausea and vomiting
- Diarrhoea
- Loss of appetite
- Hand-foot syndrome
- Skin discoloration or rash
- High blood pressure
- Headache
- Hair loss
- Changes in taste
- Dry skin or itching
- Nosebleeds
Brand
Hetero Healthcare LTD
Related products
Zyrop 4000 IU injection
Recombinant Human Erythropoietin Alfa/epoetin Alfa
Zybev 100mg Injection
Bevacizumab
Zyceva 100mg Tablet
Erlotinib
Zpac 100mg Injection
Paclitaxel